Premium
Rapid assessment of salivary MMP‐8 and periodontal disease using lateral flow immunoassay
Author(s) -
Johnson N,
Ebersole JL,
Kryscio RJ,
Danaher RJ,
Dawson D,
AlSabbagh M,
Miller CS
Publication year - 2016
Publication title -
oral diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.953
H-Index - 87
eISSN - 1601-0825
pISSN - 1354-523X
DOI - 10.1111/odi.12521
Subject(s) - saliva , immunoassay , medicine , periodontitis , periodontal disease , matrix metalloproteinase , gold standard (test) , dentistry , pathology , immunology , antibody
Objective The objective of this study was to determine the efficacy of a novel point‐of‐care immunoflow device (POCID) for detecting matrix metalloproteinase (MMP)‐8 concentrations in oral fluids in comparison with a gold standard laboratory‐based immunoassay. Methods Oral rinse fluid and whole expectorated saliva samples were collected from 41 participants clinically classified as periodontally healthy or diseased. Samples were analyzed for MMP‐8 by Luminex immunoassay and POCID. Photographed POCID results were assessed by optical scan and visually by two examiners. Data were analyzed by Pearson's correlation and receiver‐operating characteristics. Results MMP‐8 was readily detected by the POCID, and concentrations correlated well with Luminex for both saliva and rinse fluids (r = 0.57–0.93). Thresholds that distinguished periodontitis from health were delineated from both the optical scans and visual reads of the POCID (sensitivity: 0.7–0.9, specificity: 0.5–0.7; P < 0.05). Conclusions Performance of this POCID for detecting MMP‐8 in oral rinse fluid or saliva was excellent. These findings help demonstrate the utility of salivary biomarkers for distinguishing periodontal disease from health using a rapid point‐of‐care approach.